Mechanism of procyanidin b2 in the treatment of chronic myeloid leukemia based on integrating network pharmacology and molecular docking.
Anti-cancer agents in medicinal chemistry（2023）
Abstract
Through integrating network pharmacology combined with molecular docking, the study revealed the potential mechanism of PCB2 anti-chronic myeloid leukemia.
MoreTranslated text
Key words
procyanidin b2,chronic myeloid leukemia,integrating network pharmacology,molecular docking
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined